Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab

In this study we employed a comprehensive immune profiling approach to determine innate and adaptive immune response to SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis receiving rituximab. By multicolour cytometry, dendritic and natural killer cells, B- and T-cell subsets,...

Descripción completa

Detalles Bibliográficos
Autores principales: Damato, Valentina, Spagni, Gregorio, Monte, Gabriele, Scandiffio, Letizia, Cavalcante, Paola, Zampetti, Nicole, Fossati, Marco, Falso, Silvia, Mantegazza, Renato, Battaglia, Alessandra, Fattorossi, Andrea, Evoli, Amelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922162/
https://www.ncbi.nlm.nih.gov/pubmed/36842303
http://dx.doi.org/10.1016/j.nmd.2023.02.005

Ejemplares similares

Ejemplares similares